SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

NovaBay Pharmaceuticals, Inc. – ‘10-K’ for 12/31/15 – ‘XML’

On:  Friday, 3/4/16, at 5:31pm ET   ·   For:  12/31/15   ·   Accession #:  1437749-16-26877   ·   File #:  1-33678

Previous ‘10-K’:  ‘10-K/A’ on 4/14/15 for 12/31/14   ·   Next:  ‘10-K’ on 3/23/17 for 12/31/16   ·   Latest:  ‘10-K/A’ on 3/29/24 for 12/31/23   ·   5 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/04/16  NovaBay Pharmaceuticals, Inc.     10-K       12/31/15   81:8.7M                                   RDG Filings/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.37M 
 2: EX-10.19    Material Contract                                   HTML     23K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML     24K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     30K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     25K 
14: R1          Document And Entity Information                     HTML     53K 
15: R2          Consolidated Balance Sheets                         HTML     99K 
16: R3          Consolidated Balance Sheets (Parentheticals)        HTML     37K 
17: R4          Consolidated Statements of Operations and           HTML     70K 
                Comprehensive Loss                                               
18: R5          Consolidated Statements of Stockholders' Equity     HTML    126K 
19: R6          Consolidated Statements of Cash Flows               HTML    111K 
20: R7          Note 1 - Organization                               HTML     32K 
21: R8          Note 2 - Summary of Significant Accounting          HTML    108K 
                Policies                                                         
22: R9          Note 3 - Fair Value Measurements                    HTML     82K 
23: R10         Note 4 - Inventory                                  HTML     41K 
24: R11         Note 5 - Property and Equipment                     HTML     47K 
25: R12         Note 6 - Accrued Liabilities                        HTML     42K 
26: R13         Note 7 - Related Party Notes Payable                HTML     35K 
27: R14         Note 8 - Commitments and Contingencies              HTML     43K 
28: R15         Note 9 - Warrant Liability                          HTML     91K 
29: R16         Note 10 - Stockholders' Equity                      HTML     81K 
30: R17         Note 11 - Equity-based Compensation                 HTML    193K 
31: R18         Note 12 - License, Collaboration and Distribution   HTML     92K 
                Agreements                                                       
32: R19         Note 13 - Employee Benefit Plan                     HTML     27K 
33: R20         Note 14 - Income Taxes                              HTML    172K 
34: R21         Note 15 - Subsequent Events                         HTML     30K 
35: R22         Accounting Policies, by Policy (Policies)           HTML    170K 
36: R23         Note 2 - Summary of Significant Accounting          HTML     70K 
                Policies (Tables)                                                
37: R24         Note 3 - Fair Value Measurements (Tables)           HTML     79K 
38: R25         Note 4 - Inventory (Tables)                         HTML     40K 
39: R26         Note 5 - Property and Equipment (Tables)            HTML     45K 
40: R27         Note 6 - Accrued Liabilities (Tables)               HTML     41K 
41: R28         Note 8 - Commitments and Contingencies (Tables)     HTML     36K 
42: R29         Note 9 - Warrant Liability (Tables)                 HTML     80K 
43: R30         Note 10 - Stockholders' Equity (Tables)             HTML     57K 
44: R31         Note 11 - Equity-based Compensation (Tables)        HTML    181K 
45: R32         Note 12 - License, Collaboration and Distribution   HTML     76K 
                Agreements (Tables)                                              
46: R33         Note 14 - Income Taxes (Tables)                     HTML    173K 
47: R34         Note 1 - Organization (Details)                     HTML     39K 
48: R35         Note 2 - Summary of Significant Accounting          HTML     45K 
                Policies (Details)                                               
49: R36         Note 2 - Summary of Significant Accounting          HTML     41K 
                Policies (Details) - Reconciliation of Basic and                 
                Diluted EPS                                                      
50: R37         Note 2 - Summary of Significant Accounting          HTML     32K 
                Policies (Details) - Antidilutive Securities                     
51: R38         Note 3 - Fair Value Measurements (Details)          HTML     26K 
52: R39         Note 3 - Fair Value Measurements (Details) -        HTML     39K 
                Assets and Liabilities Measured at Fair Value on a               
                Recurring Basis                                                  
53: R40         Note 3 - Fair Value Measurements (Details) - Fair   HTML     35K 
                Value of Warrant Liability                                       
54: R41         Note 4 - Inventory (Details) - Inventory            HTML     36K 
55: R42         Note 5 - Property and Equipment (Details)           HTML     26K 
56: R43         Note 5 - Property and Equipment (Details) -         HTML     41K 
                Property and Equipment Summary                                   
57: R44         Note 6 - Accrued Liabilities (Details) - Accrued    HTML     38K 
                Liabilities                                                      
58: R45         Note 7 - Related Party Notes Payable (Details)      HTML     63K 
59: R46         Note 8 - Commitments and Contingencies (Details)    HTML     28K 
60: R47         Note 8 - Commitments and Contingencies (Details) -  HTML     39K 
                Future Minimum Lease Payments                                    
61: R48         Note 9 - Warrant Liability (Details)                HTML     78K 
62: R49         Note 9 - Warrant Liability (Details) - The Key      HTML     41K 
                Assumptions Used to Value the Warrants                           
63: R50         Note 10 - Stockholders' Equity (Details)            HTML    149K 
64: R51         Note 10 - Stockholders' Equity (Details) -          HTML     40K 
                Outstanding Warrants                                             
65: R52         Note 11 - Equity-based Compensation (Details)       HTML     89K 
66: R53         Note 11 - Equity-based Compensation (Details) -     HTML     85K 
                Stock Options Outstanding                                        
67: R54         Note 11 - Equity-based Compensation (Details) -     HTML     44K 
                Weighted-average Assumptions Used in Determining                 
                the Value of Options Granted                                     
68: R55         Note 11 - Equity-based Compensation (Details) -     HTML     33K 
                Summary of the Stock-based Compensation Expense                  
                Included in Results of Operations                                
69: R56         Note 12 - License, Collaboration and Distribution   HTML    104K 
                Agreements (Details)                                             
70: R57         Note 12 - License, Collaboration and Distribution   HTML     45K 
                Agreements (Details) - Deferred Revenue                          
71: R58         Note 14 - Income Taxes (Details)                    HTML     33K 
72: R59         Note 14 - Income Taxes (Details) - Federal and      HTML     35K 
                State Income Tax Provisions                                      
73: R60         Note 14 - Income Taxes (Details) - Summary of       HTML     50K 
                Deferred Tax Assets and Liabilities                              
74: R61         Note 14 - Income Taxes (Details) - Valuation        HTML     26K 
                Allowance                                                        
75: R62         Note 14 - Income Taxes (Details) - Summary of Tax   HTML     35K 
                Credit Carryforwards                                             
76: R63         Note 14 - Income Taxes (Details) - Effective        HTML     46K 
                Income Tax Rate Reconciliation                                   
77: R64         Note 14 - Income Taxes (Details) - Unrecognized     HTML     28K 
                Tax Benefit                                                      
78: R65         Note 15 - Subsequent Events (Details)               HTML     57K 
80: XML         IDEA XML File -- Filing Summary                      XML    148K 
79: EXCEL       IDEA Workbook of Financial Reports                  XLSX     88K 
 8: EX-101.INS  XBRL Instance -- nby-20151231                        XML   1.96M 
10: EX-101.CAL  XBRL Calculations -- nby-20151231_cal                XML    123K 
11: EX-101.DEF  XBRL Definitions -- nby-20151231_def                 XML    849K 
12: EX-101.LAB  XBRL Labels -- nby-20151231_lab                      XML   1.18M 
13: EX-101.PRE  XBRL Presentations -- nby-20151231_pre               XML    810K 
 9: EX-101.SCH  XBRL Schema -- nby-20151231                          XSD    206K 
81: ZIP         XBRL Zipped Folder -- 0001437749-16-026877-xbrl      Zip    201K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.3.1.900 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 246 </ContextCount>
<ElementCount> 330 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 90 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 4 </UnitCount>
<MyReports>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 000 - Disclosure - Document And Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/DocumentAndEntityInformation </Role>
<ShortName> Document And Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 001 - Statement - Consolidated Balance Sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/ConsolidatedBalanceSheet </Role>
<ShortName> Consolidated Balance Sheets </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 002 - Statement - Consolidated Balance Sheets (Parentheticals) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/ConsolidatedBalanceSheet_Parentheticals </Role>
<ShortName> Consolidated Balance Sheets (Parentheticals) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 003 - Statement - Consolidated Statements of Operations and Comprehensive Loss </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/ConsolidatedIncomeStatement </Role>
<ShortName> Consolidated Statements of Operations and Comprehensive Loss </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 004 - Statement - Consolidated Statements of Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/ShareholdersEquityType2or3 </Role>
<ShortName> Consolidated Statements of Stockholders' Equity </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 005 - Statement - Consolidated Statements of Cash Flows </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/ConsolidatedCashFlow </Role>
<ShortName> Consolidated Statements of Cash Flows </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 006 - Disclosure - Note 1 - Organization </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note1Organization </Role>
<ShortName> Note 1 - Organization </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 007 - Disclosure - Note 2 - Summary of Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note2SummaryofSignificantAccountingPolicies </Role>
<ShortName> Note 2 - Summary of Significant Accounting Policies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 008 - Disclosure - Note 3 - Fair Value Measurements </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note3FairValueMeasurements </Role>
<ShortName> Note 3 - Fair Value Measurements </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 009 - Disclosure - Note 4 - Inventory </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note4Inventory </Role>
<ShortName> Note 4 - Inventory </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 010 - Disclosure - Note 5 - Property and Equipment </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note5PropertyandEquipment </Role>
<ShortName> Note 5 - Property and Equipment </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 011 - Disclosure - Note 6 - Accrued Liabilities </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note6AccruedLiabilities </Role>
<ShortName> Note 6 - Accrued Liabilities </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 012 - Disclosure - Note 7 - Related Party Notes Payable </LongName>
<ReportType> Notes </ReportType>
<Role> http://www.novabaypharma.com/role/Note7RelatedPartyNotesPayable </Role>
<ShortName> Note 7 - Related Party Notes Payable </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 013 - Disclosure - Note 8 - Commitments and Contingencies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note8CommitmentsandContingencies </Role>
<ShortName> Note 8 - Commitments and Contingencies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 014 - Disclosure - Note 9 - Warrant Liability </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note9WarrantLiability </Role>
<ShortName> Note 9 - Warrant Liability </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 015 - Disclosure - Note 10 - Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note10StockholdersEquity </Role>
<ShortName> Note 10 - Stockholders' Equity </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 016 - Disclosure - Note 11 - Equity-based Compensation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note11EquitybasedCompensation </Role>
<ShortName> Note 11 - Equity-based Compensation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 017 - Disclosure - Note 12 - License, Collaboration and Distribution Agreements </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note12LicenseCollaborationandDistributionAgreements </Role>
<ShortName> Note 12 - License, Collaboration and Distribution Agreements </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 18 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 018 - Disclosure - Note 13 - Employee Benefit Plan </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note13EmployeeBenefitPlan </Role>
<ShortName> Note 13 - Employee Benefit Plan </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 19 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 019 - Disclosure - Note 14 - Income Taxes </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note14IncomeTaxes </Role>
<ShortName> Note 14 - Income Taxes </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 20 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 020 - Disclosure - Note 15 - Subsequent Events </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note15SubsequentEvents </Role>
<ShortName> Note 15 - Subsequent Events </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 21 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 021 - Disclosure - Accounting Policies, by Policy (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/AccountingPoliciesByPolicy </Role>
<ShortName> Accounting Policies, by Policy (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note2SummaryofSignificantAccountingPolicies </ParentRole>
<Position> 22 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 022 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note2SummaryofSignificantAccountingPoliciesTables </Role>
<ShortName> Note 2 - Summary of Significant Accounting Policies (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note2SummaryofSignificantAccountingPolicies </ParentRole>
<Position> 23 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 023 - Disclosure - Note 3 - Fair Value Measurements (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note3FairValueMeasurementsTables </Role>
<ShortName> Note 3 - Fair Value Measurements (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note3FairValueMeasurements </ParentRole>
<Position> 24 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 024 - Disclosure - Note 4 - Inventory (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note4InventoryTables </Role>
<ShortName> Note 4 - Inventory (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note4Inventory </ParentRole>
<Position> 25 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 025 - Disclosure - Note 5 - Property and Equipment (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note5PropertyandEquipmentTables </Role>
<ShortName> Note 5 - Property and Equipment (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note5PropertyandEquipment </ParentRole>
<Position> 26 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 026 - Disclosure - Note 6 - Accrued Liabilities (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note6AccruedLiabilitiesTables </Role>
<ShortName> Note 6 - Accrued Liabilities (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note6AccruedLiabilities </ParentRole>
<Position> 27 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 027 - Disclosure - Note 8 - Commitments and Contingencies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note8CommitmentsandContingenciesTables </Role>
<ShortName> Note 8 - Commitments and Contingencies (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note8CommitmentsandContingencies </ParentRole>
<Position> 28 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 028 - Disclosure - Note 9 - Warrant Liability (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note9WarrantLiabilityTables </Role>
<ShortName> Note 9 - Warrant Liability (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note9WarrantLiability </ParentRole>
<Position> 29 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 029 - Disclosure - Note 10 - Stockholders' Equity (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note10StockholdersEquityTables </Role>
<ShortName> Note 10 - Stockholders' Equity (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note10StockholdersEquity </ParentRole>
<Position> 30 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 030 - Disclosure - Note 11 - Equity-based Compensation (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note11EquitybasedCompensationTables </Role>
<ShortName> Note 11 - Equity-based Compensation (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note11EquitybasedCompensation </ParentRole>
<Position> 31 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 031 - Disclosure - Note 12 - License, Collaboration and Distribution Agreements (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note12LicenseCollaborationandDistributionAgreementsTables </Role>
<ShortName> Note 12 - License, Collaboration and Distribution Agreements (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note12LicenseCollaborationandDistributionAgreements </ParentRole>
<Position> 32 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 032 - Disclosure - Note 14 - Income Taxes (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note14IncomeTaxesTables </Role>
<ShortName> Note 14 - Income Taxes (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note14IncomeTaxes </ParentRole>
<Position> 33 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 033 - Disclosure - Note 1 - Organization (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note1OrganizationDetails </Role>
<ShortName> Note 1 - Organization (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note1Organization </ParentRole>
<Position> 34 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 034 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note2SummaryofSignificantAccountingPoliciesDetails </Role>
<ShortName> Note 2 - Summary of Significant Accounting Policies (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note2SummaryofSignificantAccountingPoliciesTables </ParentRole>
<Position> 35 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 035 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Reconciliation of Basic and Diluted EPS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/ReconciliationofBasicandDilutedEPSTable </Role>
<ShortName> Note 2 - Summary of Significant Accounting Policies (Details) - Reconciliation of Basic and Diluted EPS </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note2SummaryofSignificantAccountingPoliciesTables </ParentRole>
<Position> 36 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 036 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) - Antidilutive Securities </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/AntidilutiveSecuritiesTable </Role>
<ShortName> Note 2 - Summary of Significant Accounting Policies (Details) - Antidilutive Securities </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note2SummaryofSignificantAccountingPoliciesTables </ParentRole>
<Position> 37 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 037 - Disclosure - Note 3 - Fair Value Measurements (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note3FairValueMeasurementsDetails </Role>
<ShortName> Note 3 - Fair Value Measurements (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note3FairValueMeasurementsTables </ParentRole>
<Position> 38 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 038 - Disclosure - Note 3 - Fair Value Measurements (Details) - Assets and Liabilities Measured at Fair Value on a Recurring Basis </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/AssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisTable </Role>
<ShortName> Note 3 - Fair Value Measurements (Details) - Assets and Liabilities Measured at Fair Value on a Recurring Basis </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note3FairValueMeasurementsTables </ParentRole>
<Position> 39 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 039 - Disclosure - Note 3 - Fair Value Measurements (Details) - Fair Value of Warrant Liability </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/FairValueofWarrantLiabilityTable </Role>
<ShortName> Note 3 - Fair Value Measurements (Details) - Fair Value of Warrant Liability </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note3FairValueMeasurementsTables </ParentRole>
<Position> 40 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 040 - Disclosure - Note 4 - Inventory (Details) - Inventory </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/InventoryTable </Role>
<ShortName> Note 4 - Inventory (Details) - Inventory </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note4InventoryTables </ParentRole>
<Position> 41 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 041 - Disclosure - Note 5 - Property and Equipment (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note5PropertyandEquipmentDetails </Role>
<ShortName> Note 5 - Property and Equipment (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note5PropertyandEquipmentTables </ParentRole>
<Position> 42 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 042 - Disclosure - Note 5 - Property and Equipment (Details) - Property and Equipment Summary </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/PropertyandEquipmentSummaryTable </Role>
<ShortName> Note 5 - Property and Equipment (Details) - Property and Equipment Summary </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note5PropertyandEquipmentTables </ParentRole>
<Position> 43 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 043 - Disclosure - Note 6 - Accrued Liabilities (Details) - Accrued Liabilities </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/AccruedLiabilitiesTable </Role>
<ShortName> Note 6 - Accrued Liabilities (Details) - Accrued Liabilities </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note6AccruedLiabilitiesTables </ParentRole>
<Position> 44 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 044 - Disclosure - Note 7 - Related Party Notes Payable (Details) </LongName>
<ReportType> Notes </ReportType>
<Role> http://www.novabaypharma.com/role/Note7RelatedPartyNotesPayableDetails </Role>
<ShortName> Note 7 - Related Party Notes Payable (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note7RelatedPartyNotesPayable </ParentRole>
<Position> 45 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R46.htm </HtmlFileName>
<LongName> 045 - Disclosure - Note 8 - Commitments and Contingencies (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note8CommitmentsandContingenciesDetails </Role>
<ShortName> Note 8 - Commitments and Contingencies (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note8CommitmentsandContingenciesTables </ParentRole>
<Position> 46 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R47.htm </HtmlFileName>
<LongName> 046 - Disclosure - Note 8 - Commitments and Contingencies (Details) - Future Minimum Lease Payments </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/FutureMinimumLeasePaymentsTable </Role>
<ShortName> Note 8 - Commitments and Contingencies (Details) - Future Minimum Lease Payments </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note8CommitmentsandContingenciesTables </ParentRole>
<Position> 47 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R48.htm </HtmlFileName>
<LongName> 047 - Disclosure - Note 9 - Warrant Liability (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note9WarrantLiabilityDetails </Role>
<ShortName> Note 9 - Warrant Liability (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note9WarrantLiabilityTables </ParentRole>
<Position> 48 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R49.htm </HtmlFileName>
<LongName> 048 - Disclosure - Note 9 - Warrant Liability (Details) - The Key Assumptions Used to Value the Warrants </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/TheKeyAssumptionsUsedtoValuetheWarrantsTable </Role>
<ShortName> Note 9 - Warrant Liability (Details) - The Key Assumptions Used to Value the Warrants </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note9WarrantLiabilityTables </ParentRole>
<Position> 49 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R50.htm </HtmlFileName>
<LongName> 049 - Disclosure - Note 10 - Stockholders' Equity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note10StockholdersEquityDetails </Role>
<ShortName> Note 10 - Stockholders' Equity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note10StockholdersEquityTables </ParentRole>
<Position> 50 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R51.htm </HtmlFileName>
<LongName> 050 - Disclosure - Note 10 - Stockholders' Equity (Details) - Outstanding Warrants </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/OutstandingWarrantsTable </Role>
<ShortName> Note 10 - Stockholders' Equity (Details) - Outstanding Warrants </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note10StockholdersEquityTables </ParentRole>
<Position> 51 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R52.htm </HtmlFileName>
<LongName> 051 - Disclosure - Note 11 - Equity-based Compensation (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note11EquitybasedCompensationDetails </Role>
<ShortName> Note 11 - Equity-based Compensation (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note11EquitybasedCompensationTables </ParentRole>
<Position> 52 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R53.htm </HtmlFileName>
<LongName> 052 - Disclosure - Note 11 - Equity-based Compensation (Details) - Stock Options Outstanding </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/StockOptionsOutstandingTable </Role>
<ShortName> Note 11 - Equity-based Compensation (Details) - Stock Options Outstanding </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note11EquitybasedCompensationTables </ParentRole>
<Position> 53 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R54.htm </HtmlFileName>
<LongName> 053 - Disclosure - Note 11 - Equity-based Compensation (Details) - Weighted-average Assumptions Used in Determining the Value of Options Granted </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/WeightedaverageAssumptionsUsedinDeterminingtheValueofOptionsGrantedTable </Role>
<ShortName> Note 11 - Equity-based Compensation (Details) - Weighted-average Assumptions Used in Determining the Value of Options Granted </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note11EquitybasedCompensationTables </ParentRole>
<Position> 54 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R55.htm </HtmlFileName>
<LongName> 054 - Disclosure - Note 11 - Equity-based Compensation (Details) - Summary of the Stock-based Compensation Expense Included in Results of Operations </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/SummaryoftheStockbasedCompensationExpenseIncludedinResultsofOperationsTable </Role>
<ShortName> Note 11 - Equity-based Compensation (Details) - Summary of the Stock-based Compensation Expense Included in Results of Operations </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note11EquitybasedCompensationTables </ParentRole>
<Position> 55 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R56.htm </HtmlFileName>
<LongName> 055 - Disclosure - Note 12 - License, Collaboration and Distribution Agreements (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note12LicenseCollaborationandDistributionAgreementsDetails </Role>
<ShortName> Note 12 - License, Collaboration and Distribution Agreements (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note12LicenseCollaborationandDistributionAgreementsTables </ParentRole>
<Position> 56 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R57.htm </HtmlFileName>
<LongName> 056 - Disclosure - Note 12 - License, Collaboration and Distribution Agreements (Details) - Deferred Revenue </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/DeferredRevenueTable </Role>
<ShortName> Note 12 - License, Collaboration and Distribution Agreements (Details) - Deferred Revenue </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note12LicenseCollaborationandDistributionAgreementsTables </ParentRole>
<Position> 57 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R58.htm </HtmlFileName>
<LongName> 057 - Disclosure - Note 14 - Income Taxes (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note14IncomeTaxesDetails </Role>
<ShortName> Note 14 - Income Taxes (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note14IncomeTaxesTables </ParentRole>
<Position> 58 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R59.htm </HtmlFileName>
<LongName> 058 - Disclosure - Note 14 - Income Taxes (Details) - Federal and State Income Tax Provisions </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/FederalandStateIncomeTaxProvisionsTable </Role>
<ShortName> Note 14 - Income Taxes (Details) - Federal and State Income Tax Provisions </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note14IncomeTaxesTables </ParentRole>
<Position> 59 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R60.htm </HtmlFileName>
<LongName> 059 - Disclosure - Note 14 - Income Taxes (Details) - Summary of Deferred Tax Assets and Liabilities </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/SummaryofDeferredTaxAssetsandLiabilitiesTable </Role>
<ShortName> Note 14 - Income Taxes (Details) - Summary of Deferred Tax Assets and Liabilities </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note14IncomeTaxesTables </ParentRole>
<Position> 60 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R61.htm </HtmlFileName>
<LongName> 060 - Disclosure - Note 14 - Income Taxes (Details) - Valuation Allowance </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/ValuationAllowanceTable </Role>
<ShortName> Note 14 - Income Taxes (Details) - Valuation Allowance </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note14IncomeTaxesTables </ParentRole>
<Position> 61 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R62.htm </HtmlFileName>
<LongName> 061 - Disclosure - Note 14 - Income Taxes (Details) - Summary of Tax Credit Carryforwards </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/SummaryofTaxCreditCarryforwardsTable </Role>
<ShortName> Note 14 - Income Taxes (Details) - Summary of Tax Credit Carryforwards </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note14IncomeTaxesTables </ParentRole>
<Position> 62 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R63.htm </HtmlFileName>
<LongName> 062 - Disclosure - Note 14 - Income Taxes (Details) - Effective Income Tax Rate Reconciliation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/EffectiveIncomeTaxRateReconciliationTable </Role>
<ShortName> Note 14 - Income Taxes (Details) - Effective Income Tax Rate Reconciliation </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note14IncomeTaxesTables </ParentRole>
<Position> 63 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R64.htm </HtmlFileName>
<LongName> 063 - Disclosure - Note 14 - Income Taxes (Details) - Unrecognized Tax Benefit </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/UnrecognizedTaxBenefitTable </Role>
<ShortName> Note 14 - Income Taxes (Details) - Unrecognized Tax Benefit </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note14IncomeTaxesTables </ParentRole>
<Position> 64 </Position>
</Report>
<Report instance="nby-20151231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R65.htm </HtmlFileName>
<LongName> 064 - Disclosure - Note 15 - Subsequent Events (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.novabaypharma.com/role/Note15SubsequentEventsDetails </Role>
<ShortName> Note 15 - Subsequent Events (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.novabaypharma.com/role/Note15SubsequentEvents </ParentRole>
<Position> 65 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File> nby-20151231.xml </File>
<File> nby-20151231.xsd </File>
<File> nby-20151231_cal.xml </File>
<File> nby-20151231_def.xml </File>
<File> nby-20151231_lab.xml </File>
<File> nby-20151231_pre.xml </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies/>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/04/22  NovaBay Pharmaceuticals, Inc.     S-1                    5:953K                                   RDG Filings/FA
12/01/21  NovaBay Pharmaceuticals, Inc.     S-1                   15:1.1M                                   RDG Filings/FA
 3/25/21  NovaBay Pharmaceuticals, Inc.     10-K       12/31/20  101:10M                                    RDG Filings/FA
11/12/20  NovaBay Pharmaceuticals, Inc.     10-Q        9/30/20   89:10M                                    RDG Filings/FA
 8/06/20  NovaBay Pharmaceuticals, Inc.     10-Q        6/30/20   93:10M                                    RDG Filings/FA
↑Top
Filing Submission 0001437749-16-026877   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Thu., May 16, 2:09:57.2pm ET